Monash Infectious Disease

800+ infectious disease researchers.
4 infectious disease departments in leading health services.
10+ locations across Australia and 15+ locations across the world.
$366m+ in infectious disease funding awarded 2015-2020.

Explore our Monash Infectious Disease snapshot (2020-2021) (PDF, 31.17 MB)

Selected Monash Infectious Disease experts

Professor Stephen Turner

Stephen studies factors that regulate virus-specific T cell recruitment and differentiation after infection.
Professor Allen Cheng

Allen is a specialist in infectious diseases and an epidemiologist.
Professor Sophia Zoungas

Sophia is an endocrinologist and a leading clinician scientist and trialist.

-

Monash Infectious Disease news

‘Bioprospecting’ uncovers viruses that can kill deadly superbugs

In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting’ for viruses known as phages that can kill deadly superbugs.

2023 Fellows of the Australian Academy of Science, Professor Mariapia Degli-Esposti and Professor Jian Li

Viral immunologist and antimicrobial pharmacologist elected Academy Fellows

Two researchers from the Monash Biomedicine Discovery Institute (BDI) have been elected as 2023 Fellows of the Australian Academy of Science, Australia’s most prestigious honour in science. Professor Mariapia Degli-Esposti and

Dr Jinxin Zhao finalist for the Premier’s Award for Health and Medical Research

A Monash Biomedicine Discovery Institute researcher has been named a finalist in the 2022 Premier’s Awards for Health and Medical Research.

Professor Jill Banfield

Professor Jill Banfield joins the Monash Biomedicine Discovery Institute

Professor Jill Banfield FRS FAA, one of the world’s leading microbiologists, has joined the Monash BDI on a fractional appointment. Professor Banfield also holds a position at UC Berkeley.

Microscopy of fluorescent STING (eGFP-STING, in yellow) co-localising with ESCRT protein HRS shown in cyan and ubiquitin shown in magenta. These interactions were found to be involved in STING transport to the lysosome, the rubbish disposal system

‘ESCRT’ing a key immune protein to its demise to control inflammation

Monash University researchers have discovered a key mechanism in the body’s immune system that helps control the inflammatory response to infection. The discovery could help pave the way for more targeted therapies in a range of inflammatory

Associate Professor Tony Velkov

Future antibiotic development supported with ARC funding

Monash Biomedicine Discovery Institute (BDI) researcher Associate Professor Tony Velkov has secured a highly competitive ARC Mid-Career Industry Fellowship to expand future antibiotic development.

Pictured (L-R) A/Prof Tony Velkov and Prof Jian Li, recent recipients of two R01 NIH Grants.

More than $11M in prestigious grants awarded to researchers to combat antibiotic resistance

The World Health Organization (WHO) has continually highlighted antibiotic resistance as one of today’s most significant threats to the global community. Faced with rapidly growing antibiotic resistance, there is an urgent need to discover new

Neutralizing the bacterially derived cytotoxic bomb: the pneumococci lie in the background, an array of macrophages and dendritic cells are arranged around the central image of a T cell. Rows of TCRs interacting with the identified pneumolysin

Near-universal T cell immunity towards a broad range of bacteria

Typically, T cells of the immune system respond to a specific feature (antigen) of a microbe, thereby generating protective immunity. As reported in the journal Immunity, an international team of scientists have discovered an exception to this rule.

(L-R) Co-first author and PhD student Stephanie Studniberg with senior researcher, Monash BDI’s Professor Diana Hansen. Image credit: WEHI

Discovery identifies those likely to experience life-threatening dengue fever

Scientists have discovered cell populations in blood which clearly indicate whether a person infected with dengue fever is likely to progress to life-threatening severe disease or not.